In addition, a correlation between CXCR4 expression and therapeutic response was observed in NSCLC and TNBC tumor models, suggesting that CXCR4 imaging could be used for identification of tumors most responsive to CXCR4-targeted therapies. This evidence concerns the gene CXCR4 and neoplasm.